Biothus - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $92,159.49 +1.85%
Ethereum $3,333.28 +6.73%
BNB $890.30 +0.38%
Optimism $0.33 +3.27%
Arbitrum $0.22 +1.16%
Solana $137.84 +3.75%
Polygon $0.22 +2.77%
Cosmos $2.26 +0.29%
Avalanche $14.29 +4.45%

Bitcoin $92,159.49 +1.85%
Ethereum $3,333.28 +6.73%
BNB $890.30 +0.38%
Optimism $0.33 +3.27%
Arbitrum $0.22 +1.16%
Solana $137.84 +3.75%
Polygon $0.22 +2.77%
Cosmos $2.26 +0.29%
Avalanche $14.29 +4.45%

Biothus

company

Summary
Funding Rounds
Investors

About

Biothus is a pharmaceutical company, focused on antibody-based drugs

11 - 50

Highlights

Total Funding Amount

Details

Last Funding Type: Series A
Last Funding Money Raised: ¥180M
Industries: Biotechnology,Health Care
Founded date: Feb 1, 2018
Number Of Employee: 11 - 50
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥180M

Biothus has raised a total of ¥180M in funding over 2 rounds. Their latest funding was raised on Oct 30, 2018 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 30, 2018	Series A	¥180M	1	Zhuhai Huajin Asset	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

1

Biothus is funded by 1 investors. Zhuhai Huajin Asset are the most recent investors.

Investor Name	Lead Investor	Funding Round
Zhuhai Huajin Asset	Yes	Series A